Literature DB >> 7528574

Soluble kit receptor in human serum.

J Wypych1, L G Bennett, M G Schwartz, C L Clogston, H S Lu, V C Broudy, T D Bartley, V P Parker, K E Langley.   

Abstract

c-kit encodes the transmembrane receptor tyrosine kinase (Kit) for the recently described ligand stem cell factor (SCF). We have developed an enzyme-linked immunosorbent assay for measuring soluble human Kit and we have used the assay to show high levels of soluble Kit in human serum. The distribution of soluble Kit levels was investigated among 112 normal human serum donors. The mean serum level (+/- SD) was found to be 324 +/- 105 ng/mL with the values falling between 163 ng/mL and 788 ng/mL. No correlation between soluble Kit levels and the sexes or ages of the donors was found. Partial purification using immunoaffinity chromatography allowed us to characterize the soluble Kit from pooled human serum. Antibodies generated to a 497-amino acid recombinant human soluble Kit corresponding to the N-terminal extracellular domain of the receptor recognized the serum-derived soluble Kit by immunoblotting. We found that the serum-derived soluble Kit is glycosylated, with mostly N-linked but also O-linked carbohydrate, and with terminal sialic acid residues. When compared with the recombinant human soluble Kit, the serum-derived material was similar both in size and glycosylation pattern. CNBr cleavage of the isolated serum-derived material followed by amino terminal sequencing confirmed the presence of five peptides expected for the extracellular portion of the Kit molecule. The immunoaffinity purified serum-derived soluble Kit inhibited binding of [125I]SCF to membrane-bound receptor in an in vitro assay. These results indicate that soluble Kit could modulate the activity and functions of SCF in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528574

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases.

Authors:  Kenneth Verstraete; Savvas N Savvides
Journal:  Nat Rev Cancer       Date:  2012-10-18       Impact factor: 60.716

2.  Stem cell factor potentiates histamine secretion by multiple mechanisms, but does not affect tumour necrosis factor-alpha release from rat mast cells.

Authors:  T J Lin; E Y Bissonnette; A Hirsh; A D Befus
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

3.  The expression of KIT receptor dimers in gastrointestinal stromal tumors independent of c-kit mutation and SCF expression is associated with high-risk stratification.

Authors:  Cen Qiu; Xiaohong Liu; Chenguang Bai; DA Lie Ma
Journal:  Oncol Lett       Date:  2012-07-11       Impact factor: 2.967

4.  Significance of stem cell factor and soluble KIT in patients with systemic lupus erythematosus.

Authors:  T Kitoh; H Ishikawa; S Sawada; K Koshino; Y Tokano; H Hashimoto; S Nakagawa
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

5.  Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure.

Authors:  Samuel E Deprimo; Xin Huang; Martin E Blackstein; Christopher R Garrett; Charles S Harmon; Patrick Schöffski; Manisha H Shah; Jaap Verweij; Charles M Baum; George D Demetri
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

6.  Development of a Soluble KIT Electrochemical Aptasensor for Cancer Theranostics.

Authors:  Saeromi Chung; Jason K Sicklick; Partha Ray; Drew A Hall
Journal:  ACS Sens       Date:  2021-05-19       Impact factor: 9.618

7.  Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy.

Authors:  Kristina Sonnenschein; Jan Fiedler; David de Gonzalo-Calvo; Ke Xiao; Angelika Pfanne; Annette Just; Carolin Zwadlo; Samira Soltani; Udo Bavendiek; Theresia Kraft; Cristobal Dos Remedios; Serghei Cebotari; Johann Bauersachs; Thomas Thum
Journal:  Sci Rep       Date:  2021-01-19       Impact factor: 4.379

8.  Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity.

Authors:  Joanna S Makowska; Malgorzata Cieslak; Marek L Kowalski
Journal:  BMC Pulm Med       Date:  2009-06-01       Impact factor: 3.317

9.  Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins.

Authors:  Samuel E Deprimo; Carlo L Bello; John Smeraglia; Charles M Baum; Dominic Spinella; Brian I Rini; M Dror Michaelson; Robert J Motzer
Journal:  J Transl Med       Date:  2007-07-02       Impact factor: 5.531

10.  Residues 39-56 of Stem Cell Factor Protein Sequence Are Capable of Stimulating the Expansion of Cord Blood CD34+ Cells.

Authors:  Bin Shen; Wenhong Jiang; Jie Fan; Wei Dai; Xinxin Ding; Yongping Jiang
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.